Literature DB >> 12739028

Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature.

L Rodríguez-Mañas1, J Angulo, S Vallejo, C Peiró, A Sánchez-Ferrer, E Cercas, P López-Dóriga, C F Sánchez-Ferrer.   

Abstract

AIMS/HYPOTHESIS: In a model of streptozotocin-induced Type 1 diabetes mellitus in rats of 9 weeks duration, we analysed time associations between the development of hyperglycaemia, early and intermediate glycosylation Amadori adducts, or AGE compared with enhancement of oxidative stress and endothelial dysfunction.
METHODS: Endothelial function was tested at several stages of streptozotocin-induced diabetes and after treatment with insulin, resulting in different concentrations of blood glucose, glycosylated haemoglobin (an Amadori adduct), and AGE. Other animals were studied antagonising the formation of AGE with aminoguanidine.
RESULTS: Relaxation in response to acetylcholine (1 nmol/l to 10 micro mol/l) was tested in isolated segments from aorta or mesenteric microvessels. Impairment of endothelium-dependent relaxations occurred after 2 weeks of untreated diabetes. Preincubation of vessels affected with 100 U/ml superoxide dismutase improved the relaxations to acetylcholine, along the time-course of the endothelial impairment. This indicates the participation of reactive oxygen species on diabetic endothelial dysfunction. The impairment of endothelium-dependent relaxations was recovered after 3 more weeks of insulin treatment. Aminoguanidine treatment did not modify this pattern of development. The time course of the rise and disappearance of endothelial dysfunction showed a higher correlation with glycosylated haemoglobin concentrations than with blood glucose or serum AGE. CONCLUSION/
INTERPRETATION: Enhancement of early and intermediate Amadori adducts of protein glycosylation was the factor showing a better relation with the development of endothelium impairment. These results are consistent with a role for these products in the development of diabetic vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739028     DOI: 10.1007/s00125-003-1056-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  64 in total

1.  Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats.

Authors:  L Rodríguez-Mañas; J Angulo; C Peiró; J L Llergo; A Sánchez-Ferrer; P López-Dóriga; C F Sánchez-Ferrer
Journal:  Br J Pharmacol       Date:  1998-04       Impact factor: 8.739

2.  Local 24-h hyperglycemia does not affect endothelium-dependent or -independent vasoreactivity in humans.

Authors:  A J Houben; N C Schaper; C H de Haan; F C Huvers; D W Slaaf; P W de Leeuw; C Nieuwenhuijzen Kruseman
Journal:  Am J Physiol       Date:  1996-06

3.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation.

Authors:  L Virág; P Jagtap; E Szabó; J G Mabley; L Liaudet; A Marton; D G Hoyt; K G Murthy; A L Salzman; G J Southan; C Szabó
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

4.  Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels.

Authors:  S Vallejo; J Angulo; C Peiró; J Nevado; A Sánchez-Ferrer; R Petidier; C F Sánchez-Ferrer; L Rodríguez-Mañas
Journal:  Diabetologia       Date:  2000-01       Impact factor: 10.122

Review 5.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

6.  Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration.

Authors:  G M Pieper
Journal:  Diabetologia       Date:  1999-02       Impact factor: 10.122

7.  Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals.

Authors:  D Diederich; J Skopec; A Diederich; F X Dai
Journal:  Am J Physiol       Date:  1994-03

8.  Possible superoxide radical-induced alteration of vascular reactivity in aortas from streptozotocin-treated rats.

Authors:  K C Chang; S Y Chung; W S Chong; J S Suh; S H Kim; H K Noh; B W Seong; H J Ko; K W Chun
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

9.  The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery.

Authors:  P D Taylor; L Poston
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

10.  Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes.

Authors:  A Calver; J Collier; P Vallance
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more
  26 in total

1.  FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.

Authors:  M El Assar; J M Sánchez-Puelles; I Royo; E López-Hernández; A Sánchez-Ferrer; J L Aceña; L Rodríguez-Mañas; J Angulo
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  [The role of AGEs and ROS in atherosclerosis].

Authors:  Alin Stirban
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

Review 3.  Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation.

Authors:  Hamdy Nassar; Alpdogan Kantarci; Thomas E van Dyke
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

4.  Moderate exercise ameliorates dysregulated hippocampal glycometabolism and memory function in a rat model of type 2 diabetes.

Authors:  Takeru Shima; Takashi Matsui; Subrina Jesmin; Masahiro Okamoto; Mariko Soya; Koshiro Inoue; Yu-Fan Liu; Ignacio Torres-Aleman; Bruce S McEwen; Hideaki Soya
Journal:  Diabetologia       Date:  2016-12-08       Impact factor: 10.122

5.  Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells.

Authors:  Julián Nevado; Concepción Peiró; Susana Vallejo; Mariam El-Assar; Nuria Lafuente; Nuria Matesanz; Verónica Azcutia; Elena Cercas; Carlos F Sánchez-Ferrer; Leocadio Rodríguez-Mañas
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Sexual dimorphism in rat aortic endothelial function of streptozotocin-induced diabetes: possible involvement of superoxide and nitric oxide production.

Authors:  Xiaoyuan Han; Rui Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2013-11-06       Impact factor: 4.432

7.  Pro-inflammatory effects of early non-enzymatic glycated proteins in human mesothelial cells vary with cell donor's age.

Authors:  L Rodríguez-Mañas; C Sánchez-Rodríguez; S Vallejo; M El-Assar; C Peiró; V Azcutia; N Matesanz; C F Sánchez-Ferrer; J Nevado
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

8.  Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

Authors:  S Cellek; W Qu; A M Schmidt; S Moncada
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

9.  Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes.

Authors:  Yingchun Han; Edward Randell; Sudesh Vasdev; Vicki Gill; Vereesh Gadag; Leigh Anne Newhook; Marie Grant; Donna Hagerty
Journal:  Mol Cell Biochem       Date:  2007-06-27       Impact factor: 3.396

10.  Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice.

Authors:  Jeong-Ho Oak; Ji-Youn Youn; Hua Cai
Journal:  Cardiovasc Diabetol       Date:  2009-12-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.